Physician profile
Tara Smith
NPI 1801250253
$2,350.98
in general payments reported to CMS, 2019-2025
21 companies · $443 in 2025
The $443 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $663 · 2022: $1,049 · 2023: $28.32 · 2024: $168 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $849.55 | 2022 | |
| Smith+Nephew, INC. | $368.71 | 2021-2025 | Renasys Touch, Collagenase Santyl, Grafix Pl |
| Astrazeneca Pharmaceuticals LP | $151.51 | 2021 | |
| Organogenesis INC. | $150.07 | 2025 | Apligraf, Puraply Wound Matrix |
| Amgen INC. | $120.65 | 2021 | |
| Kerecis Limited | $113.98 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Abiomed | $113.33 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.39 | 2022 | |
| Insulet Corporation | $60.97 | 2021 | |
| Amarin Pharma, INC. | $60.55 | 2021 | |
| Tactile Systems Technology INC | $51.15 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Pfizer INC. | $44.13 | 2021 | |
| Eisai INC. | $41.94 | 2021 | |
| Paratek Pharmaceuticals, INC. | $23.18 | 2025 | Nuzyra |
| Integra Lifesciences Corporation | $20.15 | 2025 | Tcc-Ez |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $19.89 | 2025 | |
| Boston Scientific Corporation | $17.94 | 2021 | |
| Solventum Corporation | $15.57 | 2025 | Activ.A.C. |
| Biohaven Pharmaceuticals, INC. | $14.31 | 2021 | |
| Cashflow Solutions, LLC | $13.47 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Teva Pharmaceuticals USA, INC. | $11.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.